ApoEko mice, compared to low-density lipoprotein receptor-deficient (LDLRko) mice, have more pronounced endothelial dysfunction and endothelial disruption under the metabolic challenge of an atherogenic diet due to reduced protective activated protein-C-PAR1 signaling. The gene discussed is VLDLR; the disease is endothelial dysfunction.